Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
wet AMD
Pharma
Clearside's CLS-AX excels in phase 2b trial, set for phase 3
Clearside’s CLS-AX has aced a phase 2b trial, achieving primary and secondary outcomes for patients with neovascular age-related macular degeneration.
Kevin Dunleavy
Oct 9, 2024 11:47am
Roche to reintroduce eye implant Susvimo 2 years after recall
Jul 8, 2024 5:10pm
Genentech animated short spotlights docs' trust in Vabysmo
May 13, 2024 4:05pm
Roche's Vabysmo shows durability in retinal vein occlusion
Oct 10, 2023 10:21am
Battling Roche's Vabysmo, Regeneron's Eylea shows durability
Aug 10, 2023 11:44am
Roche opens up the world with new ad for Vabysmo
Apr 25, 2023 4:50pm
